Next Generation Sequencing (NGS) Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245432

Publication Date:

September 3, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Next Generation Sequencing (NGS) Service is a high-throughput sequencing technology that can quickly and efficiently sequence large amounts of DNA or RNA samples. This kind of service is widely used in genetic disease research, HLA typing, cancer research, infectious disease research and other fields.
The global market for Next Generation Sequencing (NGS) Service was estimated to be worth US$ 4628.2 million in 2023 and is forecast to a readjusted size of US$ 15180 million by 2030 with a CAGR of 17.3% during the forecast period 2024-2030
The Rise of Personalized Medicine: With advances in genomics and precision medicine, more patients and healthcare providers are beginning to realize the potential of personalized medicine. NGS services can be used for genetic testing and disease prediction, and can provide patients with personalized treatment plans, helping to improve treatment effects and patients' quality of life.
Integration of big data and artificial intelligence: The amount of data generated by NGS is huge. Through big data analysis and artificial intelligence technology, these data can be better analyzed to provide more accurate diagnostic results and more effective treatment suggestions. Artificial intelligence can also help analyze complex data sets and improve the accuracy and reliability of NGS services.
Development of telemedicine services: With the development of Internet and mobile communication technology, telemedicine services are gradually emerging. NGS services can be provided remotely. Patients can perform genetic testing at home, and doctors can analyze the results and provide treatment plans remotely. This provides patients with convenient and fast services and provides doctors with a broader range of services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing (NGS) Service by region & country, by Type, and by Application.
The Next Generation Sequencing (NGS) Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Service.
Market Segmentation
By Company
454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Segment by Type:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next Generation Sequencing (NGS) Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next Generation Sequencing (NGS) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next Generation Sequencing (NGS) Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Next Generation Sequencing (NGS) Service Product Introduction
1.2 Global Next Generation Sequencing (NGS) Service Market Size Forecast
1.3 Next Generation Sequencing (NGS) Service Market Trends & Drivers
1.3.1 Next Generation Sequencing (NGS) Service Industry Trends
1.3.2 Next Generation Sequencing (NGS) Service Market Drivers & Opportunity
1.3.3 Next Generation Sequencing (NGS) Service Market Challenges
1.3.4 Next Generation Sequencing (NGS) Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next Generation Sequencing (NGS) Service Players Revenue Ranking (2023)
2.2 Global Next Generation Sequencing (NGS) Service Revenue by Company (2019-2024)
2.3 Key Companies Next Generation Sequencing (NGS) Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next Generation Sequencing (NGS) Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Next Generation Sequencing (NGS) Service
2.6 Next Generation Sequencing (NGS) Service Market Competitive Analysis
2.6.1 Next Generation Sequencing (NGS) Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next Generation Sequencing (NGS) Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Targeted Sequencing & Resequencing
3.1.2 Whole Genome Sequencing
3.1.3 Whole Exome Sequencing
3.2 Global Next Generation Sequencing (NGS) Service Sales Value by Type
3.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next Generation Sequencing (NGS) Service Sales Value, by Type (2019-2030)
3.2.3 Global Next Generation Sequencing (NGS) Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Whole-genome Sequencing
4.1.2 Exome Sequencing
4.1.3 Targeted Resequencing
4.1.4 De Novo Sequencing
4.1.5 RNA Sequencing
4.1.6 ChIP Sequencing
4.1.7 Methyl Sequencing
4.1.8 Others
4.2 Global Next Generation Sequencing (NGS) Service Sales Value by Application
4.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next Generation Sequencing (NGS) Service Sales Value, by Application (2019-2030)
4.2.3 Global Next Generation Sequencing (NGS) Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region
5.1.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2019-2024)
5.1.3 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2025-2030)
5.1.4 Global Next Generation Sequencing (NGS) Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
5.2.2 North America Next Generation Sequencing (NGS) Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
5.3.2 Europe Next Generation Sequencing (NGS) Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
5.4.2 Asia Pacific Next Generation Sequencing (NGS) Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
5.5.2 South America Next Generation Sequencing (NGS) Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next Generation Sequencing (NGS) Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next Generation Sequencing (NGS) Service Sales Value
6.3 United States
6.3.1 United States Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.3.2 United States Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.4.2 Europe Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.5.2 China Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.6.2 Japan Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.7.2 South Korea Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.8.2 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next Generation Sequencing (NGS) Service Sales Value, 2019-2030
6.9.2 India Next Generation Sequencing (NGS) Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next Generation Sequencing (NGS) Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 454 Life Sciences Corporation (Roche)
7.1.1 454 Life Sciences Corporation (Roche) Profile
7.1.2 454 Life Sciences Corporation (Roche) Main Business
7.1.3 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.1.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.1.5 454 Life Sciences Corporation (Roche) Recent Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Profile
7.2.2 Agilent Technologies Main Business
7.2.3 Agilent Technologies Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.2.4 Agilent Technologies Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies Recent Developments
7.3 Biomatters, Ltd
7.3.1 Biomatters, Ltd Profile
7.3.2 Biomatters, Ltd Main Business
7.3.3 Biomatters, Ltd Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.3.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.3.5 CLC Bio Recent Developments
7.4 CLC Bio
7.4.1 CLC Bio Profile
7.4.2 CLC Bio Main Business
7.4.3 CLC Bio Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.4.4 CLC Bio Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.4.5 CLC Bio Recent Developments
7.5 GATC biotech AG
7.5.1 GATC biotech AG Profile
7.5.2 GATC biotech AG Main Business
7.5.3 GATC biotech AG Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.5.4 GATC biotech AG Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.5.5 GATC biotech AG Recent Developments
7.6 Macrogen
7.6.1 Macrogen Profile
7.6.2 Macrogen Main Business
7.6.3 Macrogen Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.6.4 Macrogen Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.6.5 Macrogen Recent Developments
7.7 BGI (Beijing Genomics Institute)
7.7.1 BGI (Beijing Genomics Institute) Profile
7.7.2 BGI (Beijing Genomics Institute) Main Business
7.7.3 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.7.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.7.5 BGI (Beijing Genomics Institute) Recent Developments
7.8 Illumina
7.8.1 Illumina Profile
7.8.2 Illumina Main Business
7.8.3 Illumina Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.8.4 Illumina Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.8.5 Illumina Recent Developments
7.9 Life Technology Corporation
7.9.1 Life Technology Corporation Profile
7.9.2 Life Technology Corporation Main Business
7.9.3 Life Technology Corporation Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.9.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.9.5 Life Technology Corporation Recent Developments
7.10 EMC Corporation
7.10.1 EMC Corporation Profile
7.10.2 EMC Corporation Main Business
7.10.3 EMC Corporation Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.10.4 EMC Corporation Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.10.5 EMC Corporation Recent Developments
7.11 Dnastar
7.11.1 Dnastar Profile
7.11.2 Dnastar Main Business
7.11.3 Dnastar Next Generation Sequencing (NGS) Service Products, Services and Solutions
7.11.4 Dnastar Next Generation Sequencing (NGS) Service Revenue (US$ Million) & (2019-2024)
7.11.5 Dnastar Recent Developments
8 Industry Chain Analysis
8.1 Next Generation Sequencing (NGS) Service Industrial Chain
8.2 Next Generation Sequencing (NGS) Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next Generation Sequencing (NGS) Service Sales Model
8.5.2 Sales Channel
8.5.3 Next Generation Sequencing (NGS) Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂